- Home
- PBYI vs SPCE Comparison
PBYI vs SPCE Comparison
Compare PBYI & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- SPCE
- Stock Information
- Founded
- PBYI 2010
- SPCE 2017
- Country
- PBYI United States
- SPCE United States
- Employees
- PBYI N/A
- SPCE N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- SPCE Transportation Services
- Sector
- PBYI Health Care
- SPCE Consumer Discretionary
- Exchange
- PBYI Nasdaq
- SPCE Nasdaq
- Market Cap
- PBYI 153.2M
- SPCE 187.1M
- IPO Year
- PBYI N/A
- SPCE N/A
- Fundamental
- Price
- PBYI $3.09
- SPCE $5.32
- Analyst Decision
- PBYI Strong Buy
- SPCE Hold
- Analyst Count
- PBYI 1
- SPCE 6
- Target Price
- PBYI $7.00
- SPCE $25.50
- AVG Volume (30 Days)
- PBYI 754.5K
- SPCE 1.7M
- Earning Date
- PBYI 02-27-2025
- SPCE 02-25-2025
- Dividend Yield
- PBYI N/A
- SPCE N/A
- EPS Growth
- PBYI 492.79
- SPCE N/A
- EPS
- PBYI 0.47
- SPCE N/A
- Revenue
- PBYI $243,569,000.00
- SPCE $9,416,000.00
- Revenue This Year
- PBYI N/A
- SPCE $5.88
- Revenue Next Year
- PBYI N/A
- SPCE N/A
- P/E Ratio
- PBYI $6.63
- SPCE N/A
- Revenue Growth
- PBYI 6.30
- SPCE 93.74
- 52 Week Low
- PBYI $2.23
- SPCE $5.23
- 52 Week High
- PBYI $7.73
- SPCE $43.20
- Technical
- Relative Strength Index (RSI)
- PBYI 49.17
- SPCE 33.68
- Support Level
- PBYI $2.92
- SPCE $5.23
- Resistance Level
- PBYI $4.06
- SPCE $6.74
- Average True Range (ATR)
- PBYI 0.29
- SPCE 0.39
- MACD
- PBYI 0.01
- SPCE -0.07
- Stochastic Oscillator
- PBYI 27.07
- SPCE 5.83
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures advanced air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.